Novo Nordisk A/S NVO
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.27B | 7.60B | 4.19B | 3.13B | 4.03B |
| Total Depreciation and Amortization | 561.03M | 550.17M | 480.85M | 507.06M | 569.51M |
| Total Amortization of Deferred Charges | -- | -- | 49.57M | -- | -- |
| Total Other Non-Cash Items | 2.69B | 821.42M | -6.71B | 4.36B | 545.48M |
| Change in Net Operating Assets | 2.07B | -5.20B | 3.17B | -776.96M | 1.21B |
| Cash from Operations | 8.59B | 3.77B | 1.19B | 7.22B | 6.35B |
| Capital Expenditure | -1.97B | -1.77B | -2.87B | -2.13B | -2.23B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 156.49M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.85M | -62.80M | -3.96B | -281.49M | 82.60M |
| Cash from Investing | -1.99B | -1.83B | -6.67B | -2.42B | -2.15B |
| Total Debt Issued | 18.77B | 15.98B | 30.62B | 713.00M | 45.24B |
| Total Debt Repaid | -26.11B | -1.23B | -1.15B | -1.15B | -64.86B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -3.50B | -2.40B | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | -5.53B | 0.00 | -2.61B | -- |
| Other Financing Activities | -8.29B | 5.53B | -- | -- | -27.90B |
| Cash from Financing | -2.98B | -2.73B | 4.59B | -2.68B | -7.20B |
| Foreign Exchange rate Adjustments | 8.09M | -43.22M | 16.52M | 9.87M | -123.21M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.63B | -835.83M | -875.96M | 2.14B | -3.12B |